Position in ASND
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,459,526
+$103,107 QoQ
Shares Held
6,381
+0.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC WORLD MARKET INC. holds $46,729,574 across 25 Biotechnology names. ASND ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
488,266 | $13,100,176 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,078 | $12,537,950 | |
| 3 | MRNA |
Moderna, Inc.
|
69,817 | $3,546,703 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,766 | $2,909,762 | |
| 5 | RPRX |
Royalty Pharma plc
|
47,426 | $2,275,025 | |
| 6 | EXEL |
Exelixis, Inc.
|
38,204 | $1,638,569 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
6,381 | $1,459,526 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
69,215 | $1,254,867 |
All Filings in ASND
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,459,526 | 6,381 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,356,419 | 6,361 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,226,260 | 6,168 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||